Search filters

List of works by Alberto Zaniboni

DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer.

scientific article published on 21 December 2017

First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh)

scientific article published on 19 September 2017

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

scientific article

Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review

scientific article

Proxies of quality of life in metastatic colorectal cancer: analyses in the RECOURSE trial

scientific article published on 23 November 2017

Randomized trial of TAS-102 for refractory metastatic colorectal cancer

scientific article published on May 2015

Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer pha

scientific article published on 20 July 2017

Paulina is supported by:

About Paulina

Help